Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease

Journal of Infection

Volumn 34, Issue 2, 1997, Pages 147-150

  Ohga, S ^a   Ikeuchi, K ^a   Kadoya, R ^a   Okada, K ^a   Miyazaki, C ^a   Suita, S ^a   Ueda, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CLINICAL FEATURE; HUMAN; INFANT; LUNG INFECTION; MALE; MEDIASTINITIS; MYCOBACTERIUM AVIUM;

EID: 0030934530     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(97)92509-3     Document Type: Article

References (20)

1. Smith MHD, Starke JR, Marquis JR. Tuberculosis and opportunistic mycobacterial infections. In: Feigin RD, Cherry JD, Eds. Textbook of pediatric infectious diseases. Philadelphia: WB Saunders, 1992: 1321-1362.
2. Tellis CJ. Pulmonary disease caused by nontuberculosis mycobacteria, Symposium on Infectious Lung Diseases. Med Clin North Am 1980; 64: 433-446.
3. Boggs DS. The changing spectrum of pulmonary infections due to nontuberculous mycobacteria. J Okla State Med Assoc 1995; 88: 373-382.
4. + T cells. J Exp Med 1992; 176: 581-586.
5. Ishii E, Irita K, Fujita I et al. Protein phosphorylation of neutrophils from normal children and patients with chronic granulomatous disease. Eur J Pediatr 1986; 145: 22-26.
6. Ohga S, Okamura J, Nakayama H, Nagatoshi Y, Ueda K. Interferon-γ therapy for infection control in chronic granulomatous disease Acta Paediatr Jpn 1995; 37: 315-320.
7. Smith JA, Weidemann MJ. Further characterization of the neutrophil oxidative burst by flow cytometry. J Immunol Methods 1993; 162: 261-268.
8. Mizuno Y, Hara T, Nakamura M, Ueda K, Minakami S, Take H. Classification of chronic granulomatous disease on the basis of monoclonal antibody-defined surface cytochrome b deficiency. J Pediatr 1988; 116: 458-462.
9. Qui PG. Chronic granulomatous disease of childhood: a saga of discovery and understanding. Pediatr Infect Dis J 1993; 12: 395-398.
10. Smith RM, Curnutte JT. Molecular basis of chronic granulomatous disease. Blood 1991; 77: 673-686.
11. Yang KD, Hill HR. Neutrophil function disorders: Pathophysiology, prevention, and therapy. J Pediatr 1991; 119: 343-354.
12. Allen DM, Chng HH. Disseminated Mycobacterium flavescens in a probable case of chronic granulomatous disease. J Infect 1993; 26: 83-86.
13. Chusid MJ, Parrillo JE, Fauci AS. Chronic granulomatous disease: diagnosis in a 27-year-old man with Mycobacterium fortuitum. JAMA 1975; 233: 1295-1296.
14. Moskaluk CA, Pogrebniak HW, Pass HI, Gallin JI, Travis WD. Surgical pathology of the lung in chronic granulomatous disease. Am J Clin Pathol 1994; 102: 684-691.
15. Gonzalez B, Moreno S, Burdach R, et al. Clinical presentation of Bacillus Calmette-Guerin infections in patients with immunodeficiency syndrome. Pediatr Infect Dis 1989; 8: 201-206.
16. Jones GS, Amirault HJ, Andersen BR. Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process. J Infect Dis 1990; 162: 700-704.
17. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukocyte Biol 1991; 49: 380-387.
18. Murray HW. Interferon-gamma and host antimicrobial defense: current and future clinical applications. Am J Med 1994; 97: 459-467.
19. + (memory T) cells in patients with chronic granulomatous disease. J Infect Dis 1993; 167: 983-985.
20. Holland SM, Eisenstein E, Kuhns DB et al. Treatment of refractory disseminated non-tuberculosis mycobacterial infection with interferon-gamma. N Engl J Med 1994; 330: 1348-1355.